Ras-MEK-ERK signaling cascade regulates androgen receptor element-inducible gene transcription and DNA synthesis in prostate cancer cellsCAREY, Anne-Marie; PRAMANIK, Rashida; NICHOLSON, Linda J et al.International journal of cancer. 2007, Vol 121, Num 3, pp 520-527, issn 0020-7136, 8 p.Article

Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma - results of the UK HD3 relapse treatment strategySHANKAR, Ananth; HAYWARD, Janis; KIRKWOOD, Amy et al.British journal of haematology. 2014, Vol 165, Num 4, pp 534-544, issn 0007-1048, 11 p.Article

Chronic Lymphocytic Leukemia: Treatment Options for Patients With Refractory DiseaseMOTTA, Marina; WIERDA, William G; FERRAJOLI, Alessandra et al.Cancer. 2009, Vol 115, Num 17, pp 3830-3841, issn 0008-543X, 12 p.Article

Phase 2 study of arsenic trioxide in patients with relapsed or refractory multiple myelomaHUSSEIN, Mohamad A; SALEH, Mansoor; RAVANDI, Farhad et al.British journal of haematology. 2004, Vol 125, Num 4, pp 470-476, issn 0007-1048, 7 p.Article

Molecular markers in the diagnosis of prostate cancerVAN DER POEL, H. G.Critical reviews in oncology/hematology. 2007, Vol 61, Num 2, pp 104-139, issn 1040-8428, 36 p.Article

Long-term treatment of relapsing Wegener's granulomatosis with 15-deoxyspergualinFLOSSMANN, Oliver; JAYNE, David R. W.Rheumatology (Oxford. Print). 2010, Vol 49, Num 3, pp 556-562, issn 1462-0324, 7 p.Article

Dopamine D₂ receptor polymorphisms in inflammatory Bowel disease and the refractory response to treatmentMAGRO, F; CUNHA, E; ARAUJO, F et al.Digestive diseases and sciences. 2006, Vol 51, Num 11, pp 2039-2044, issn 0163-2116, 6 p.Article

On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testingSHAN MAN; MUNOZ, Raquel; KERBEL, Robert S et al.Cancer metastasis reviews. 2007, Vol 26, Num 3-4, pp 737-747, issn 0167-7659, 11 p.Article

Pemetrexed in patients with refractory soft tissue sarcoma: A non-comparative multicenter phase II study of the German Sarcoma Group AIO-STS 005HARTMANN, J. T; BAUER, S; EGERER, G et al.Investigational new drugs. 2013, Vol 31, Num 1, pp 167-174, issn 0167-6997, 8 p.Article

Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkersZAJA, Francesco; DE LUCA, Stefano; BALZAROTTI, Monica et al.Haematologica (Roma). 2012, Vol 97, Num 3, pp 416-422, issn 0390-6078, 7 p.Article

Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable diseaseROSINOL, Laura; GARCIA-SANZ, Ramón; CARLOS GARCIA-RUIZ, Juan et al.Haematologica (Roma). 2012, Vol 97, Num 4, pp 616-621, issn 0390-6078, 6 p.Article

Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II studyPECTASIDES, D; PECTASIDES, M; FARMAKIS, D et al.Annals of oncology. 2004, Vol 15, Num 3, pp 493-497, issn 0923-7534, 5 p.Article

How to manage high-risk acute myeloid leukemiaESTEY, E. H.Leukemia. 2012, Vol 26, Num 5, pp 861-869, issn 0887-6924, 9 p.Article

Response to induction chemotherapy is not essential to obtain survival benefit from high-dose melphalan and autotransplantation in myelomaSINGHAL, S; POWLES, R; SIROHI, B et al.Bone marrow transplantation (Basingstoke). 2002, Vol 30, Num 10, pp 673-679, issn 0268-3369, 7 p.Article

Effect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivoSHABBIR, Majid; THOMPSON, Cecil; JARMULOWICZC, Michael et al.BJU international (Papier). 2008, Vol 102, Num 1, pp 108-112, issn 1464-4096, 5 p.Article

Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel diseaseSANKARAN-WALTERS, Sumathi; RANSIBRAHMANAKUL, Kanat; GRISHINA, Irina et al.Journal of clinical virology. 2011, Vol 50, Num 1, pp 31-36, issn 1386-6532, 6 p.Article

Management of recurrent ovarian cancer with systemic therapyPOVEDA, Andrés.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 1, pp 29-36, issn 1359-6349, 8 p.Article

A phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma: Cancer and leukemia group B 99813OH, William K; HALABI, Susan; KELLY, W. Kevin et al.Cancer. 2003, Vol 98, Num 12, pp 2592-2598, issn 0008-543X, 7 p.Article

Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: A phase II studyPECTASIDES, Dimitrios; PECTASIDES, Melina; RAPTIS, Sotirios A et al.European urology. 2004, Vol 46, Num 2, pp 216-221, issn 0302-2838, 6 p.Article

The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II studySCHEY, Stephen A; MORGAN, Gareth J; RAMASAMY, Karthik et al.British journal of haematology. 2010, Vol 150, Num 3, pp 326-333, issn 0007-1048, 8 p.Article

Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 studyWANG, Michael; POPPLEWELL, Leslie L; TUSCANO, Joseph M et al.British journal of haematology. 2014, Vol 165, Num 4, pp 510-518, issn 0007-1048, 9 p.Article

Docetaxel chemotherapy for metastatic hormone refractory prostate cancer as first-line palliative chemotherapy and subsequent re-treatment : Birmingham experienceANSARI, Jawaher; ANWER HUSSAIN, Syed; ZARKAR, Anjali et al.Oncology reports. 2008, Vol 20, Num 4, pp 891-896, issn 1021-335X, 6 p.Article

Fixed-Dose-Rate Gemcitabine in Combination with Oxaliplatin in Patients with Metastatic Pancreatic Cancer Refractory to Standard-Dose-Rate Gemcitabine : A Single-Institute StudyFORTUNE, Brett E; XIAOBAI LI; KOSURI, Kavitha V et al.Oncology. 2009, Vol 76, Num 5, pp 333-337, issn 0030-2414, 5 p.Article

Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiationMORI, Yasuo; AOKI, Takatoshi; TESHIMA, Takanori et al.International journal of hematology. 2010, Vol 91, Num 1, pp 107-111, issn 0925-5710, 5 p.Article

Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients : A phase II study with a 5-year follow-upBERRUTI, Alfredo; FARA, Enrica; DE STEFANIS, Marinella et al.Urologic oncology. 2005, Vol 23, Num 1, pp 1-7, issn 1078-1439, 7 p.Article